Navigation Links
BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
Date:1/6/2009

LYNBROOK, N.Y., Jan. 6 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (OTC Bulletin Board: BSTC), a biopharmaceutical company developing first in class collagenase based products, today announced that it has received notification from The NASDAQ Stock Market LLC that its common stock has been approved for listing on the NASDAQ Global Market. The Company's common stock will begin trading January 9, 2009 on NASDAQ at market open under the symbol "BSTC" and will end trading on the OTC Bulletin Board at the close of market on January 8, 2009.

"This listing on NASDAQ marks the culmination of a transformational year for us at BioSpecifics, and we believe it will greatly benefit our stockholders by enhancing our liquidity and overall visibility," stated Thomas L. Wegman, President of BioSpecifics. "In 2008, we announced positive Phase 3 clinical results for our collagenase product XIAFLEX(TM) for Dupuytren's disease and our partner Auxilium initiated the Phase 2b trial for Peyronie's disease. In addition, Auxilium just announced a major European licensing agreement with Pfizer, in which BioSpecifics will receive a share of both the upfront payment and sales and regulatory milestones. We are very much looking forward to further progress, including the filing with the U.S. Food and Administration of the Biologic License Application of XIAFLEX early this year."

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed and partnered, injectable collagenase for three clinical indications: Dupuytren's disease, Peyronie's disease, and frozen shoulder (adhesive capsulitis). It has a development and licensing agreement with Auxilium Pharmaceuticals, Inc. Positive top line results from the Phase III clinical trials with XIAFLEX(TM) for treatment of Dupuytren's disease were released in June 2008. Based on those positive Phase III results, Auxilium expects to file a
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
2. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
3. BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
4. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
5. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
6. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
7. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
8. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
9. BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):UAB bone center director wins distinguished service award from clinical pathology society 2Why King Kong failed to impress 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4UPDATE 3A FDA Issues 22 Warning Letters to Web site Operators 6415 1UPDATE 3A FDA Issues 22 Warning Letters to Web site Operators 6415 2Weill Cornell science briefs 3A November 2009 10815 1Weill Cornell science briefs 3A November 2009 10815 2Weill Cornell science briefs 3A November 2009 10815 3Weill Cornell science briefs 3A November 2009 10815 4Weill Cornell science briefs 3A November 2009 10815 5Lifeway Foods Reports Record 3rd Quarter 2009 Revenues and Earnings Results 61739 1Lifeway Foods Reports Record 3rd Quarter 2009 Revenues and Earnings Results 61739 2Lifeway Foods Reports Record 3rd Quarter 2009 Revenues and Earnings Results 61739 3Lifeway Foods Reports Record 3rd Quarter 2009 Revenues and Earnings Results 61739 4Lifeway Foods Reports Record 3rd Quarter 2009 Revenues and Earnings Results 61739 5Lifeway Foods Reports Record 3rd Quarter 2009 Revenues and Earnings Results 61739 6Lifeway Foods Reports Record 3rd Quarter 2009 Revenues and Earnings Results 61739 7Lifeway Foods Reports Record 3rd Quarter 2009 Revenues and Earnings Results 61739 8